Literature DB >> 7496978

Use of zidovudine in human immunodeficiency virus-induced hepatitis.

D L Wertheim1, E Valderamma, V R Bonagura.   

Abstract

Hepatitis is a common complication of human immunodeficiency virus (HIV) disease in children. Often a distinct pathogen cannot be identified. Therefore, by exclusion, one must consider HIV the direct pathogen. Zidovudine (AZT) has not been used as a treatment for HIV-positive children with presumed HIV-induced hepatitis because of the potential of this medication to exacerbate preexisting hepatitis. We have used AZT to treat an 8-month-old female with severe HIV-induced hepatitis and have achieved complete remission with this regimen. For some HIV-positive children with HIV-induced hepatitis, AZT may be the drug of choice to resolve hepatic inflammation caused by this virus.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7496978      PMCID： PMC368264          DOI： 10.1128/cdli.1.3.361-363.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  16 in total

1.  Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).

Authors:  D J Schneiderman; D M Arenson; J P Cello; W Margaretten; T E Weber
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

Review 2.  Hepatic histopathology in the acquired immunodeficiency syndrome.

Authors:  N Bach; N D Theise; F Schaffner
Journal:  Semin Liver Dis       Date:  1992-05       Impact factor: 6.115

3.  Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS).

Authors:  B J Glasgow; K Anders; L J Layfield; K D Steinsapir; G L Gitnick; K J Lewin
Journal:  Am J Clin Pathol       Date:  1985-05       Impact factor: 2.493

4.  Zidovudine-induced hepatotoxicity.

Authors:  G Dubin; M N Braffman
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

5.  Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study.

Authors:  S A Kahn; B R Saltzman; R S Klein; P S Mahadevia; G H Friedland; L J Brandt
Journal:  Am J Gastroenterol       Date:  1986-12       Impact factor: 10.864

6.  Hepatitis in children with acquired immune deficiency syndrome. Histopathologic and immunocytologic features.

Authors:  L F Duffy; F Daum; E Kahn; S Teichberg; R Pahwa; J Fagin; K Kenigsberg; M Kaplan; S E Fisher; S Pahwa
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

7.  Pathologic features of the liver in acquired immune deficiency syndrome (AIDS).

Authors:  Y Nakanuma; C T Liew; R L Peters; S Govindarajan
Journal:  Liver       Date:  1986-06

8.  Autopsy findings in the acquired immune deficiency syndrome.

Authors:  K Welch; W Finkbeiner; C E Alpers; W Blumenfeld; R L Davis; E A Smuckler; J H Beckstead
Journal:  JAMA       Date:  1984-09-07       Impact factor: 56.272

9.  The spectrum of liver disease in the acquired immunodeficiency syndrome.

Authors:  S C Gordon; K R Reddy; E E Gould; R McFadden; C O'Brien; M De Medina; L J Jeffers; E R Schiff
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Peliosis hepatis in the acquired immunodeficiency syndrome.

Authors:  C A Czapar; C M Weldon-Linne; D M Moore; D P Rhone
Journal:  Arch Pathol Lab Med       Date:  1986-07       Impact factor: 5.534
View more
  1 in total

1.  Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.

Authors:  Antonella Esposito; Valentina Conti; Maria Cagliuso; Daniele Pastori; Alessandra Fantauzzi; Ivano Mezzaroma
Journal:  AIDS Res Ther       Date:  2011-03-01       Impact factor: 2.250
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.